InSysBio to take part in ACoP13

events
Conference
October 12, 2022

October 12, 2022

InSysBio announces its participation in the Thirteenth American Conference on Pharmacometrics (ACoP13) which is to be held in person from October 30th to November 2nd, 2022, at the Gaylord Rockies Resort & Convention Center in Aurora, Colorado. The theme of ACoP13 is “Together Moving Mountains”. InSysBio team is going to present 7 posters in frames of the Conference, namely:

Monday, October 31

  • M-006: "Virtual Patients Parallel Simulations in a Hybrid Cloud Environment" by Ivan Borisov, Evgeny Metelkin, Tatiana Karelina, Oleg Demin
  • M-057: "Quantitative systems pharmacology model for neurofilament L dynamics in multiple sclerosis and under immunomodulatory therapies" by Polina Pchelintseva

Tuesday, November 1

  • T-040: "Quantitative systems pharmacology modeling of immune response role in Parkinson’s disease" by Tatiana Karelina
  • T-051: "Methodological aspects of rate law derivation of cell dynamics processes: focus on QSP model development" by Oleg Demin, Maria Mironovich, Julia Sergienko
  • T-054: "Estimation of Imax and IC50 for PD1-PDL1 inhibition of T cell proliferation" by Oleg Demin
  • T-061: "The QSP model of microglia role in tau pathology and neurodegeneration" by Stepan Lerner
  • T-065: "Pharmacokinetics modeling and optimal dose prediction for a bispecific antibody against CD40 and PD1" by Alexandra Diakonova, Oleg Demin Jr, Dmitry Shchelokov, Oleg Demin

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Edinburgh, UK (INSYSBIO UK LIMITED), Cyprus (INSYSBIO CY Ltd) and Moscow, Russia (INSYSBIO LLC). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

 

August 2020
MoTuWeThFrSaSu
     
1
2
3
1. 03 Aug 2020 16:00 InSysBio to share new data in frames of its Open Source QSP model of COVID-19 InSysBio has received a new set of results in framework of development of QSP model of COVID-19 describing virus and host cell life cycles, innate and adoptive immune response and possible therapeutic treatments.
4
5
6
1. 06 Aug 2020 17:51 InSysBio to update its Cytocon DB and to present version 1.2.6.6 InSysBio is glad to present Cytocon DB 1.2.6.6! Cytocon DB team has reviewed 39 articles to introduce new data. It should be outlined that the total number of concentrations within the Database has already exceeded 10 thousand!
7
8
9
10
11
12
13
14
15
16
17
18
19
20
1. 20 Aug 2020 17:18 InSysBio to present the new version of Immune Response Template IRT 3.2.0 acquires new models and extended annotations (Moscow – 20.08.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents the new version of its Immune Response Template (IRT). IRT is an efficient and useful tool to boost and facilitate the development of QSP models in immunology and immuno-oncology therapeutic areas. By this point IRT has been developed into a fully-fledged database but InSysBio constantly goes further in its software advancement.
21
22
23
24
25
26
27
28
29
30
31
      
Upcoming Events
Tags
Latest News
10.09
InSysBio team to publish the new article in PSPJournal
04.09
InSysBio to launch Immune Response Template version 3.6.3 for QSP modeling
22.02
14th InSysBio’s Annual Internal Scientific Meeting
24.01
InSysBio to present the new Plugin for Sublime Text and Heta compiler Online
07.12
InSysBio to release public beta of fIVE Calculator